|
|
Volumn 289, Issue 11, 2003, Pages 1363-1364
|
|
Tensions Remain over tPA for Stroke
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
TISSUE PLASMINOGEN ACTIVATOR;
ANTITHROMBOCYTIC AGENT;
FIBRINOLYTIC AGENT;
IMMUNOGLOBULIN F(AB) FRAGMENT;
MONOCLONAL ANTIBODY;
BRAIN HEMORRHAGE;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
DISEASE COURSE;
DISEASE ONSET;
DRUG APPROVAL;
DRUG EFFICACY;
EMERGENCY TREATMENT;
FOOD AND DRUG ADMINISTRATION;
HEALTH EDUCATION;
HUMAN;
LAW SUIT;
LEGAL ASPECT;
OUTCOMES RESEARCH;
PATIENT CARE;
PATIENT TRANSPORT;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
REVIEW;
RISK BENEFIT ANALYSIS;
STATISTICAL ANALYSIS;
STROKE;
VALIDATION PROCESS;
ARTICLE;
CEREBROVASCULAR ACCIDENT;
EMERGENCY MEDICINE;
MALPRACTICE;
RISK;
TIME;
ANTIBODIES, MONOCLONAL;
CEREBROVASCULAR ACCIDENT;
EMERGENCY MEDICINE;
FIBRINOLYTIC AGENTS;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
MALPRACTICE;
PLATELET AGGREGATION INHIBITORS;
RISK;
TIME FACTORS;
TISSUE PLASMINOGEN ACTIVATOR;
|
|
EID: 0037454262
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.289.11.1363 Document Type: Review |
|
Times cited : (15)
|
|
References (0)
|